DK0891186T3 - Nasal administration af middel til behandling af forsinket opkastning - Google Patents

Nasal administration af middel til behandling af forsinket opkastning

Info

Publication number: DK0891186T3
Authority: DK; Denmark
Prior art keywords: agent; treatment; nasal administration; delayed vomiting; delayed
Prior art date: 1996-03-14

Application number

DK97915060.4T

Other languages

English (en)

Inventor

Mary Psilogenis

Original Assignee

Evoke Pharma Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-03-14

Filing date

1997-03-13

Publication date

2011-03-14

1997-03-13 Application filed by Evoke Pharma Inc filed Critical Evoke Pharma Inc

2011-03-14 Application granted granted Critical

2011-03-14 Publication of DK0891186T3 publication Critical patent/DK0891186T3/da

Links

206010047700 Vomiting Diseases 0.000 title abstract 2
230000003111 delayed effect Effects 0.000 title abstract 2
230000008673 vomiting Effects 0.000 title 1
TTWJBBZEZQICBI-UHFFFAOYSA-N metoclopramide Chemical compound CCN(CC)CCNC(=O)C1=CC(Cl)=C(N)C=C1OC TTWJBBZEZQICBI-UHFFFAOYSA-N 0.000 abstract 1
229960004503 metoclopramide Drugs 0.000 abstract 1
239000007922 nasal spray Substances 0.000 abstract 1
229940097496 nasal spray Drugs 0.000 abstract 1
230000000069 prophylactic effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Otolaryngology (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Hospice & Palliative Care (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

DK97915060.4T 1996-03-14 1997-03-13 Nasal administration af middel til behandling af forsinket opkastning DK0891186T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US08/616,121 US5760086A (en)	1996-03-14	1996-03-14	Nasal administration of agents for treatment of delayed onset emesis
PCT/US1997/003974 WO1997033573A1 (en)	1996-03-14	1997-03-13	Nasal administration of agents for treatment of delayed onset emesis

Publications (1)

Publication Number	Publication Date
DK0891186T3 true DK0891186T3 (da)	2011-03-14

Family

ID=24468120

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK97915060.4T DK0891186T3 (da)	1996-03-14	1997-03-13	Nasal administration af middel til behandling af forsinket opkastning

Country Status (24)

Country	Link
US (1)	US5760086A (da)
EP (1)	EP0891186B1 (da)
JP (1)	JP2000507234A (da)
KR (1)	KR100420673B1 (da)
CN (1)	CN1217657A (da)
AT (1)	ATE489137T1 (da)
AU (1)	AU707467B2 (da)
BG (1)	BG102780A (da)
CA (1)	CA2248968C (da)
CZ (1)	CZ289797B6 (da)
DE (1)	DE69740060D1 (da)
DK (1)	DK0891186T3 (da)
EE (1)	EE03665B1 (da)
ES (1)	ES2357520T3 (da)
IL (1)	IL126199A (da)
NO (1)	NO984245L (da)
NZ (1)	NZ331991A (da)
PL (1)	PL328940A1 (da)
PT (1)	PT891186E (da)
RU (1)	RU2181588C2 (da)
SK (1)	SK282695B6 (da)
UA (1)	UA57733C2 (da)
WO (1)	WO1997033573A1 (da)
YU (1)	YU40398A (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6770262B2 (en) *	2000-03-30	2004-08-03	Questcor Pharmaceuticals, Inc.	Nasal administration of agents for the treatment of gastroparesis
RU2344813C1 (ru) *	2007-04-26	2009-01-27	Федеральное государственное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова Федерального агентства по здравоохранению и социальному развитию	Способ предупреждения послеоперационной тошноты и рвоты у детей
EA019809B9 (ru) *	2008-11-11	2014-08-29	Юнилевер Нв	Композиция черного чая
US20130213393A1 (en)	2009-12-22	2013-08-22	Evoke Pharma, Inc.	Nasal formulations of metoclopramide
US8334281B2 (en) *	2008-12-22	2012-12-18	Evoke Pharma, Inc.	Nasal formulations of metoclopramide
US20110165143A1 (en) *	2010-01-06	2011-07-07	The Regents Of The University Of Colorado, A Body Corporate	Modulation of caspases and therapeutical applications
CA2846340A1 (en)	2011-08-25	2013-02-28	Matthew J. D'onofrio	Treatment of symptoms associated with female gastroparesis
FR2980976B1 (fr)	2011-10-10	2015-10-16	Mohamed Skiba	Composition pharmaceutique pour l'administration par voie nasale de la metopimazine
CN104606136A (zh) *	2015-01-06	2015-05-13	中国人民解放军军事医学科学院毒物药物研究所	甲氧氯普胺鼻腔喷雾剂、其制备方法及用途
EP3554489A4 (en)	2016-12-15	2020-06-17	Evoke Pharma, Inc.	TREATMENT FROM MODERATE TO HEAVY GASTROPARESIS

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8412585D0 (en) *	1984-05-17	1984-06-20	Beecham Group Plc	Composition
US4624965A (en) *	1984-11-15	1986-11-25	Nastech Pharmaceutical Co., Inc.	Novel method of administering anti-nausea and anti-emetic pharmaceutical agents and novel dosage forms containing same
DE4131276B4 (de) *	1990-09-28	2007-07-19	Solvay Pharmaceuticals Gmbh	Peroral applizierbare Metoclopramidlösungen

1996
- 1996-03-14 US US08/616,121 patent/US5760086A/en not_active Expired - Lifetime
1997
- 1997-03-13 KR KR10-1998-0707237A patent/KR100420673B1/ko not_active Expired - Lifetime
- 1997-03-13 SK SK1259-98A patent/SK282695B6/sk unknown
- 1997-03-13 EE EE9800295A patent/EE03665B1/xx not_active IP Right Cessation
- 1997-03-13 AU AU22102/97A patent/AU707467B2/en not_active Ceased
- 1997-03-13 IL IL12619997A patent/IL126199A/en not_active IP Right Cessation
- 1997-03-13 UA UA98105338A patent/UA57733C2/uk unknown
- 1997-03-13 JP JP9532838A patent/JP2000507234A/ja not_active Ceased
- 1997-03-13 PL PL97328940A patent/PL328940A1/xx unknown
- 1997-03-13 PT PT97915060T patent/PT891186E/pt unknown
- 1997-03-13 EP EP97915060A patent/EP0891186B1/en not_active Expired - Lifetime
- 1997-03-13 CZ CZ19982922A patent/CZ289797B6/cs not_active IP Right Cessation
- 1997-03-13 YU YU40398A patent/YU40398A/sh unknown
- 1997-03-13 DE DE69740060T patent/DE69740060D1/de not_active Expired - Lifetime
- 1997-03-13 ES ES97915060T patent/ES2357520T3/es not_active Expired - Lifetime
- 1997-03-13 DK DK97915060.4T patent/DK0891186T3/da active
- 1997-03-13 NZ NZ331991A patent/NZ331991A/xx not_active IP Right Cessation
- 1997-03-13 AT AT97915060T patent/ATE489137T1/de active
- 1997-03-13 CA CA002248968A patent/CA2248968C/en not_active Expired - Lifetime
- 1997-03-13 CN CN97194427A patent/CN1217657A/zh active Pending
- 1997-03-13 WO PCT/US1997/003974 patent/WO1997033573A1/en not_active Ceased
- 1997-03-13 RU RU98118578/14A patent/RU2181588C2/ru active IP Right Revival
1998
- 1998-09-14 NO NO984245A patent/NO984245L/no not_active Application Discontinuation
- 1998-09-18 BG BG102780A patent/BG102780A/xx unknown

Also Published As

Publication number	Publication date
UA57733C2 (uk)	2003-07-15
IL126199A0 (en)	1999-05-09
US5760086A (en)	1998-06-02
IL126199A (en)	2004-06-01
PL328940A1 (en)	1999-03-01
CA2248968A1 (en)	1997-09-18
YU40398A (sh)	2001-07-10
WO1997033573A1 (en)	1997-09-18
KR19990087763A (ko)	1999-12-27
ES2357520T3 (es)	2011-04-27
EE03665B1 (et)	2002-04-15
RU2181588C2 (ru)	2002-04-27
BG102780A (en)	2000-01-31
CZ289797B6 (cs)	2002-04-17
SK282695B6 (sk)	2002-11-06
KR100420673B1 (ko)	2004-07-23
EE9800295A (et)	1999-02-15
JP2000507234A (ja)	2000-06-13
DE69740060D1 (de)	2011-01-05
SK125998A3 (en)	1999-03-12
EP0891186A4 (en)	2004-03-31
CZ292298A3 (cs)	1999-03-17
NO984245D0 (no)	1998-09-14
AU2210297A (en)	1997-10-01
ATE489137T1 (de)	2010-12-15
CA2248968C (en)	2005-08-02
EP0891186A1 (en)	1999-01-20
NZ331991A (en)	2000-04-28
AU707467B2 (en)	1999-07-08
PT891186E (pt)	2011-02-25
NO984245L (no)	1998-11-11
EP0891186B1 (en)	2010-11-24
CN1217657A (zh)	1999-05-26

Publication	Publication Date	Title
DE69926806D1 (de)	2005-09-22	N-ureidoalkylpiperidine als modulatoren der aktivität der chemokinrezeptoren
DK0946507T3 (da)	2004-01-26	Substituerede pyrrolylforbindelser til behandling af inflammation
NO954427D0 (no)	1995-11-06	Hiv-proteaseinhibitorer som er anvendbare for behandling av AIDS
DE69531790D1 (de)	2003-10-23	Duschaufsatz
CY1111396T1 (el)	2015-08-05	Ρινικη χορηγηση μετοκλοπραμιδης για την αγωγη της γαστροπαρεσης
DK1032414T3 (da)	2003-09-01	Kombination af inhibitor for angiotensinomdannende enzym med et diuretikum til behandling af forstyrrelser i mikrokredsløbet
DK0888323T3 (da)	2004-08-09	Dihydrobenzofuran og beslægtede forbindelser, der er nyttige som antiinflammatoriske midler
DK0684816T3 (da)	2004-06-14	5-HT2-receptorantagonister til behandling af venöse tilstande
IL126199A0 (en)	1999-05-09	Nasal pharmaceutical composition for the treatment of delayed emesis
AU4726797A (en)	1998-05-22	Prophylactic/remedial agent
DK0910379T3 (da)	2003-08-11	Plaster til transdermal påføring af pergolid
DE69736180D1 (de)	2006-08-03	Behandlung von manischen erkrankungen
DK0625969T3 (da)	2001-04-30	Arylalkoxyphenoxyimidazolinforbindelser
DK0796256T3 (da)	2004-05-10	Fremgangsmåde til fremstilling af ranitidin
DK1017377T3 (da)	2002-03-04	Anvendelse af 6,7-substituerede 2-aminotetraliner til behandling af af cytokin fremkaldte inflammatoriske tilstande
ES2074194T3 (es)	1995-09-01	Procedimiento para la preparacion de 2-cloro-1,7-dihidropurin-6-ona y procedimiento para su purificacion.
DK0948338T3 (da)	2002-09-02	Anvendelse af et på æg baseret præparat som antidepressivt middel
GR1001393B (el)	1993-10-29	Παράγωγα ιμιδαζο[2,1-Β] 3] βενζαζεπίνης, συν?έσεις και μέ?οδος χρήσεως.
FI982513A0 (fi)	1998-11-20	Menetelmä metsäteollisuuslaitoksen tuottaman tuhkan käsittelemiseksi
UA32382A (uk)	2000-12-15	Спосіб проведення галотерапії та установка для його здійснення
MX9205607A (es)	1994-03-31	Procedimiento para la preparacion de: griseofulvina